SVIP is a molecular determinant of lysosomal dynamic stability, neurodegeneration and lifespan
Open Access
- 21 January 2021
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-17
Abstract
Missense mutations in Valosin-Containing Protein (VCP) are linked to diverse degenerative diseases including IBMPFD, amyotrophic lateral sclerosis (ALS), muscular dystrophy and Parkinson’s disease. Here, we characterize a VCP-binding co-factor (SVIP) that specifically recruits VCP to lysosomes. SVIP is essential for lysosomal dynamic stability and autophagosomal–lysosomal fusion. SVIP mutations cause muscle wasting and neuromuscular degeneration while muscle-specific SVIP over-expression increases lysosomal abundance and is sufficient to extend lifespan in a context, stress-dependent manner. We also establish multiple links between SVIP and VCP-dependent disease in our Drosophila model system. A biochemical screen identifies a disease-causing VCP mutation that prevents SVIP binding. Conversely, over-expression of an SVIP mutation that prevents VCP binding is deleterious. Finally, we identify a human SVIP mutation and confirm the pathogenicity of this mutation in our Drosophila model. We propose a model for VCP disease based on the differential, co-factor-dependent recruitment of VCP to intracellular organelles.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (K99/R00NS100988, R35NS097212)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
This publication has 50 references indexed in Scilit:
- Using natural variation in Drosophila to discover previously unknown endoplasmic reticulum stress genesProceedings of the National Academy of Sciences, 2013
- Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in miceCell Death & Disease, 2012
- Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin systemNature Cell Biology, 2012
- The Structural and Functional Basis of the p97/Valosin-containing Protein (VCP)-interacting Motif (VIM)Journal of Biological Chemistry, 2011
- Pathogenic VCP/TER94 Alleles Are Dominant Actives and Contribute to Neurodegeneration by Altering Cellular ATP Level in a Drosophila IBMPFD ModelPLOS Genetics, 2011
- FOXO/4E-BP Signaling in Drosophila Muscles Regulates Organism-wide Proteostasis during AgingCell, 2010
- Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP diseaseJournal of Cell Biology, 2009
- Valosin-containing protein disease: Inclusion body myopathy with Paget’s disease of the bone and fronto-temporal dementiaNeuromuscular Disorders, 2009
- Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementiaAmerican Journal of Medical Genetics Part A, 2008
- Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing proteinNature Genetics, 2004